278 related articles for article (PubMed ID: 2175662)
21. Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.
Weinblatt ME; Maier AL; Fraser PA; Coblyn JS
J Rheumatol; 1998 Feb; 25(2):238-42. PubMed ID: 9489813
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine.
Olsen N; Ziff M; Jasin HE
J Rheumatol; 1984 Feb; 11(1):17-21. PubMed ID: 6699830
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of chronic polyarthritis with low-dose methotrexate].
Karger T; Rau R
Dtsch Med Wochenschr; 1988 May; 113(21):839-46. PubMed ID: 3371211
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of methotrexate induced nodulosis with D-penicillamine.
Dash S; Seibold JR; Tiku ML
J Rheumatol; 1999 Jun; 26(6):1396-9. PubMed ID: 10381063
[TBL] [Abstract][Full Text] [Related]
25. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D
Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
[TBL] [Abstract][Full Text] [Related]
26. [Experience with long term low dose methotrexate treatment in rheumatoid arthritis and arthritic psoriasis].
Náfrádi L; Varga L
Orv Hetil; 1995 Jul; 136(29):1555-7. PubMed ID: 7637973
[TBL] [Abstract][Full Text] [Related]
27. Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy.
Ferraccioli G; Casatta L; Bartoli E
J Rheumatol; 1996 Sep; 23(9):1539-42. PubMed ID: 8877921
[TBL] [Abstract][Full Text] [Related]
28. Low-dose weekly oral methotrexate therapy for inflammatory arthritis.
Boh LE; Schuna AA; Pitterle ME; Adams EM; Sundstrom WR
Clin Pharm; 1986 Jun; 5(6):503-8. PubMed ID: 3720217
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis.
Weinblatt ME; Kremer JM; Coblyn JS; Maier AL; Helfgott SM; Morrell M; Byrne VM; Kaymakcian MV; Strand V
Arthritis Rheum; 1999 Jul; 42(7):1322-8. PubMed ID: 10403258
[TBL] [Abstract][Full Text] [Related]
30. [Methotrexate treatment in refractory juvenile rheumatoid arthritis].
Brik R
Harefuah; 1998 Dec; 135(11):509-11, 567. PubMed ID: 10911466
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate: clinical and immunological effects in refractory rheumatoid arthritis.
Singh Y; Sharma M; Singh RR; Kumar A; Malaviya R; Malaviya AN
J Assoc Physicians India; 1992 Oct; 40(10):658-61. PubMed ID: 1307351
[TBL] [Abstract][Full Text] [Related]
32. [The effect of D-penicillamine on the immunological indices of rheumatoid arthritis patients].
Sheĭtanov I
Vutr Boles; 1990; 29(4):59-64. PubMed ID: 2281661
[TBL] [Abstract][Full Text] [Related]
33. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
[TBL] [Abstract][Full Text] [Related]
34. [Methotrexate in the therapy of rheumatoid arthritis. Results in 30 patients].
Biasi D; Caramaschi P; Carletto A; Botto M; Codella O; Pacor ML; Bambara LM
Recenti Prog Med; 1992; 83(7-8):473-6. PubMed ID: 1529162
[TBL] [Abstract][Full Text] [Related]
35. Early beneficial effects of low dose oral methotrexate in rheumatoid arthritis.
Rao UR; Thopu AR; Naidu MU; Kumar TR
J Assoc Physicians India; 1990 May; 38(5):335-6. PubMed ID: 2387814
[TBL] [Abstract][Full Text] [Related]
36. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis.
Combe B; Didry C; Gutierrez M; Anaya JM; Sany J
Eur J Med; 1993 Mar; 2(3):153-6. PubMed ID: 8261056
[TBL] [Abstract][Full Text] [Related]
37. [Rheumatoid arthritis. Therapeutic efficacy of methotrexate and its hepatotoxic effects].
Carvallo A; Wolff C; Armas R; Villanueva P; Donoso G; Náquira N; Lobo G; Rojas C; Domic H
Rev Med Chil; 1993 Jul; 121(7):777-84. PubMed ID: 8296082
[TBL] [Abstract][Full Text] [Related]
38. Recurrent episodes of pseudoseptic arthritis in rheumatoid arthritis: response to D-penicillamine and methotrexate.
Hunter T
J Rheumatol; 1992 Sep; 19(9):1484. PubMed ID: 1433023
[No Abstract] [Full Text] [Related]
39. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
Pincus T; Marcum SB; Callahan LF
J Rheumatol; 1992 Dec; 19(12):1885-94. PubMed ID: 1294735
[TBL] [Abstract][Full Text] [Related]
40. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
